IDEXX Operations, Inc. | IDEXX Laboratories | Maine | state | 2010 | $14,662 | | tax credit/rebate |
IDEXX Distribution Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
IDEXX Laboratories, Inc. | IDEXX Laboratories | Maine | state | 2010 | undisclosed | | enterprise zone |
Emergent Biosolutions | Emergent BioSolutions | Michigan | state | 2009 | $3,090,000 | | tax credit/rebate |
SIGMA-ALDRICH BIOTECHNOLOGY L.P. | Merck KGaA (EMD) | Missouri | state | 2001 | $12,298,727 | | tax credit/rebate |
CENTOCOR BIOLOGICS, LLC SERIES 2005 | Johnson & Johnson | Missouri | state | 2006 | $386,661 | | tax credit/rebate |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | Missouri | state | 2000 | $9,064 | | tax credit/rebate |
BOEHRINGER INGELHEIM VETMEDICA, INC. | Eli Lilly | Missouri | state | 2001 | $1,119,362 | | tax credit/rebate |
PFIZER, INC. | Pfizer | Missouri | state | 2007 | $2,000,000 | | training reimbursement |
MALLINCKRODT MEDICAL, INC. | Mallinckrodt | Missouri | state | 2000 | $754,909 | | tax credit/rebate |
PFIZER, INC. | Pfizer | Missouri | state | 2000 | $315,055 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Missouri | state | 2000 | $143,438 | | tax credit/rebate |
SIGMA-ALDRICH CORPORATION | Merck KGaA (EMD) | Missouri | state | 2000 | $32,392 | | tax credit/rebate |
MALLINCKRODT MEDICAL, INC. | Mallinckrodt | Missouri | state | 2001 | $1,274,667 | | tax credit/rebate |
PHARMACIA CORPORATION | Pfizer | Missouri | state | 2002 | $3,235,374 | | tax credit/rebate |
G.D. SEARLE & COMPANY | Pfizer | Missouri | state | 2002 | $1,126,728 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Missouri | state | 2002 | $130,344 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $2,940,954 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals | Novo Holdings A/S | North Carolina | state | 2008 | $746,648 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $537,281 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $452,785 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $254,292 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $200,000 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2008 | $33,750 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2009 | $12,564,345 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $2,868,194 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2009 | $1,617,030 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2009 | $1,579,355 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $718,878 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2009 | $429,500 | | tax credit/rebate |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2009 | $74,375 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2010 | $6,007,498 | | tax credit/rebate |
Hospira, Inc. | Pfizer | North Carolina | state | 2010 | $1,665,848 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2010 | $373,801 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $372,272 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2010 | $270,783 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2010 | $203,568 | | tax credit/rebate |
Merck Sharp & Dohme Corp. | Merck | North Carolina | state | 2004 | $5,514,655 | | grant |
Hospira, Inc. | Pfizer | North Carolina | state | 2004 | $1,812,000 | | grant |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2004 | $1,120,000 | | grant |
GlaxoSmithKline Beecham Corp | GlaxoSmithKline | North Carolina | state | 2005 | $1,859,000 | | grant |
Novartis Vaccines & Diagnostics | Novartis | North Carolina | state | 2006 | $8,015,000 | | grant |
Novartis Vaccines and Diagnostics | Novartis | North Carolina | state | 2010 | $3,609,000 | | grant |
Novo Nordisk Pharmaceutical | Novo Holdings A/S | North Carolina | state | 2010 | $3,032,000 | | grant |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2008 | $18,128,934 | | tax credit/rebate |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $1,375,593 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2008 | $770,277 | | tax credit/rebate |
Biogen Idec US Limited Partnership | Biogen | North Carolina | state | 2008 | $305,070 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2008 | $196,973 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2008 | $106,315 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2008 | $36,500 | | tax credit/rebate |
Inspire Pharmaceuticals, Inc. | Merck | North Carolina | state | 2008 | $14,500 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2009 | $1,653,115 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2009 | $16,500 | | tax credit/rebate |
Novartis Consumer Health, Inc. | Novartis | Nebraska | state | 1997 | undisclosed | | tax credit/rebate |
Intervet, Inc. | Merck | Nebraska | state | 2001 | undisclosed | | tax credit/rebate |
Intervet, Inc. | Merck | Nebraska | state | 2007 | undisclosed | | tax credit/rebate |
Pfizer, Inc. | Pfizer | Nebraska | state | 2007 | undisclosed | | tax credit/rebate |
Novartis Pharmaceuticals Corp. & Affiliates | Novartis | Nebraska | state | 2007 | $452,433 | | tax credit/rebate |
Millipore Corporation | Merck KGaA (EMD) | New Hampshire | state | 2008 | $43,842 | | training reimbursement |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $345,800 | | tax credit/rebate |
Novartis | Novartis | New Jersey | state | 2005 | $810,000 | | tax credit/rebate |
Eisai, Inc. | Eisai | New Jersey | state | 2005 | $325,500 | | tax credit/rebate |
Novartis | Novartis | New Jersey | state | 2005 | $750,000 | | tax credit/rebate |
Novartis | Novartis | New Jersey | state | 2006 | $1,588,500 | | tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | New Jersey | state | 2007 | $420,000 | | tax credit/rebate |
Abbott Point of Care | Abbott Laboratories | New Jersey | state | 2009 | $246,400 | | tax credit/rebate |
ImClone Systems | Eli Lilly | New Jersey | state | 2010 | $350,000 | | tax credit/rebate |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | New Jersey | state | 2010 | $289,800 | | tax credit/rebate |
Novartis #2 | Novartis | New Jersey | state | 2005 | $2,208,840 | | Tax credit/rebate |
Novartis #1 | Novartis | New Jersey | state | 2005 | $1,142,400 | | Tax credit/rebate |
Eisai, Inc. | Eisai | New Jersey | state | 2005 | $677,820 | | Tax credit/rebate |
Celgene | Bristol-Myers Squibb | New Jersey | state | 2005 | $81,096 | | Tax credit/rebate |
Novartis #3 | Novartis | New Jersey | state | 2006 | $11,060,671 | | Tax credit/rebate |
Novo Nordisk | Novo Holdings A/S | New Jersey | state | 2007 | $1,387,680 | | Tax credit/rebate |
ImClone Systems | Eli Lilly | New Jersey | state | 2010 | $283,500 | | Tax credit/rebate |
ACTAVIS ELIZABETH LLC | Teva Pharmaceutical Industries | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
AMNEAL PHARMACEUTICALS LLC | Amneal Pharmaceuticals | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST LABORATORIES, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
FOREST RESEARCH INSTITUTE, INC. | AbbVie | New Jersey | state | | undisclosed | | tax credit/rebate; property tax abatement |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2006 | $2,697,365 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2006 | $1,599,567 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2006 | $200,144 | | enterprise zone |
Clay-Park Labs Inc. | Perrigo | New York | state | 2006 | $150,000 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2007 | $2,870,000 | | enterprise zone |
Bausch & Lomb Incorporated | Bausch Health | New York | state | 2007 | $1,123,304 | | enterprise zone |
Regeneron Pharmaceuticals Inc. | Regeneron Pharmaceuticals | New York | state | 2007 | $416,897 | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2001 | $2,439,160 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2005 | $2,246,703 | | enterprise zone |
BEN VENUE LABORATORIES, INC. | Boehringer Ingelheim | Ohio | state | 2006 | undisclosed | | enterprise zone |
BEN VENUE LABORATORIES | Boehringer Ingelheim | Ohio | state | 2007 | undisclosed | | enterprise zone |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2008 | undisclosed | | enterprise zone |
Centocor, Inc. | Johnson & Johnson | Pennsylvania | state | | $1,000,000 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $735,000 | | training reimbursement |
Aventis Pasteur USA | Sanofi | Pennsylvania | state | | $509,900 | | training reimbursement |
GlaxoSmithKline Biologicals North America | GlaxoSmithKline | Pennsylvania | state | | $316,181 | | training reimbursement |
Merck & Co., Inc. | Merck | Pennsylvania | state | | $265,000 | | training reimbursement |
BioRexis | Pfizer | Pennsylvania | state | | $250,000 | | training reimbursement |
GlaxoSmithKline | GlaxoSmithKline | Pennsylvania | state | | $200,000 | | training reimbursement |
Johnson & Johnson Merck Consumer Pharmaceuticals | Johnson & Johnson | Pennsylvania | state | | $160,000 | | training reimbursement |